Literature DB >> 20798963

Encephalopathies: the emerging diabetic complications.

Anders A F Sima1.   

Abstract

Diabetic encephalopathies are now accepted complications of diabetes. They appear to differ in type 1 and type 2 diabetes as to underlying mechanisms and the nature of resulting cognitive deficits. The increased incidence of Alzheimer's disease in type 2 diabetes is associated with insulin resistance, hyperinsulinemia and hyperglycemia, and commonly accompanying attributes such as hypercholesterolemia, hypertension and obesity. The relevance of these disorders as to the emergence of dementia and Alzheimer's disease is discussed based on epidemiological studies. The pathobiology of accumulation of β-amyloid and tau the hallmarks of Alzheimer's disease are discussed based on experimental data. Type 1 diabetic encephalopathy is likely to increase as a result of the global increase in the incidence of type 1 diabetes and its occurrence in increasingly younger patients. Alzheimer-like changes and dementia are not prominently increased in type 1 diabetes. Instead, the type 1 diabetic encephalopathy involves learning abilities, intelligence development and memory retrieval resulting in impaired school and professional performances. The major underlying component here appears to be insulin deficiency with downstream effects on the expression of neurotrophic factors, neurotransmitters, oxidative and apoptotic stressors resulting in defects in neuronal integrity, connectivity and loss commonly occurring in the still developing brain. Recent experimental data emphasize the role of impaired central insulin action and provide information as to potential therapies. Therefore, the underlying mechanisms resulting in diabetic encephalopathies are complex and appear to differ between the two types of diabetes. Major headway has been made in our understanding of their pathobiology; however, many questions remain to be clarified. In view of the increasing incidence of both type 1 and type 2 diabetes, intensified investigations are called for to expand our understanding of these complications and to find therapeutic means by which these disastrous consequences can be prevented and modified.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20798963     DOI: 10.1007/s00592-010-0218-0

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  57 in total

Review 1.  Cerebrovascular complications of diabetes: focus on stroke.

Authors:  Adviye Ergul; Aisha Kelly-Cobbs; Maha Abdalla; Susan C Fagan
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2012-06       Impact factor: 2.895

Review 2.  Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

Authors:  João M N Duarte
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

3.  50 years forward: mechanisms of hyperglycaemia-driven diabetic complications.

Authors:  Nicholas D F Russell; Mark E Cooper
Journal:  Diabetologia       Date:  2015-04-24       Impact factor: 10.122

4.  Effects of a high-caloric diet and physical exercise on brain metabolite levels: a combined proton MRS and histologic study.

Authors:  Matthias K Auer; Markus Sack; Jenny N Lenz; Mira Jakovcevski; Sarah V Biedermann; Claudia Falfán-Melgoza; Jan Deussing; Jörg Steinle; Maximilian Bielohuby; Martin Bidlingmaier; Frederik Pfister; Günter K Stalla; Gabriele Ende; Wolfgang Weber-Fahr; Johannes Fuss; Peter Gass
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-31       Impact factor: 6.200

5.  Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.

Authors:  E Candeias; A I Duarte; I Sebastião; M A Fernandes; A I Plácido; C Carvalho; S Correia; R X Santos; R Seiça; M S Santos; C R Oliveira; P I Moreira
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

6.  Diabetes and the elderly brain: sweet memories?

Authors:  Katherine Samaras; Perminder S Sachdev
Journal:  Ther Adv Endocrinol Metab       Date:  2012-12       Impact factor: 3.565

7.  Coenzyme Q10 and niacin mitigate streptozotocin- induced diabetic encephalopathy in a rat model.

Authors:  Tarek K Motawi; Hebatallah A Darwish; Manal A Hamed; Nagy S El-Rigal; Asmaa F Aboul Naser
Journal:  Metab Brain Dis       Date:  2017-05-30       Impact factor: 3.584

8.  Role of the PI3K/AKT signalling pathway in apoptotic cell death in the cerebral cortex of streptozotocin-induced diabetic rats.

Authors:  Yan Meng; Weiwei Wang; Jinsong Kang; Xinxue Wang; Liankun Sun
Journal:  Exp Ther Med       Date:  2017-03-23       Impact factor: 2.447

9.  Suppression of methylglyoxal hyperactivity by mangiferin can prevent diabetes-associated cognitive decline in rats.

Authors:  Yao-Wu Liu; Xia Zhu; Qian-Qian Yang; Qian Lu; Jian-Yun Wang; Hui-Pu Li; Ya-Qin Wei; Jia-Le Yin; Xiao-Xing Yin
Journal:  Psychopharmacology (Berl)       Date:  2013-03-26       Impact factor: 4.530

10.  Hyperactivation of working memory-related brain circuits in newly diagnosed middle-aged type 2 diabetics.

Authors:  Xiao-Song He; Zhao-Xin Wang; You-Zhi Zhu; Nan Wang; Xiaoping Hu; Da-Ren Zhang; De-Fa Zhu; Jiang-Ning Zhou
Journal:  Acta Diabetol       Date:  2014-07-04       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.